PATENT CLAIM ANALYSIS

Application Number: 15776536
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "260100"]

Abstract:
The present invention relates to compounds of formulae I and H, or pharmaceutically acceptable salts or esters thereof. Further aspects of the invention relate to pharmaceutical compositions and therapeutic uses of said compounds in the treatment of diseases of uncontrolled cell growth, proliferation and/or survival, inappropriate cellular immune responses, inappropriate cellular inflammatory responses, or neurodegenerative disorders, preferably tauopathies, even more preferably, Alzheimer's disease.

Claim (Index 2):
A compound according to  claim 1  wherein Z 1 , Z 2 , Z 3  and Z 4  are all C.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.45098
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15776574', '14772693', '15337184', '12784916', '15949799']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7406186306086954
- 35 USC 102 Novelty (BERT): 0.5336835185214149
- Combined Prediction Score: 0.7199251193999674
- Mean Citation Score: 300.366344
- Max Citation Score: 356.07635
- Similarity Product: 234.37421680294275

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test